Clinical Trials Browser

Phase 2 × Carcinoma, Ovarian Epithelial × farletuzumab × Clear all

NCT01018563 2021-12-08

An Open Label Extension Study of the Efficacy of MORAb-003

Phase 2 Terminated

3 enrolled 12 charts

Carcinoma, Ovarian Epithelial